<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Parasitol.</journal-id>
<journal-title>Frontiers in Parasitology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Parasitol.</abbrev-journal-title>
<issn pub-type="epub">2813-2424</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpara.2023.1081083</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Parasitology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Serology reveals micro-differences in <italic>Plasmodium falciparum</italic> transmission in the Hohoe municipality of Ghana</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kyei-Baafour</surname>
<given-names>Eric</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1284625"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kusi</surname>
<given-names>Kwadwo A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/606698"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Oppong</surname>
<given-names>Mavis</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Frempong</surname>
<given-names>Abena F.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aculley</surname>
<given-names>Belinda</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ofori</surname>
<given-names>Ebenezer A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Theisen</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/648734"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kweku</surname>
<given-names>Margaret</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adu</surname>
<given-names>Bright</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1113013"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hviid</surname>
<given-names>Lars</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/552972"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ofori</surname>
<given-names>Michael F.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/695667"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana</institution>, <addr-line>Accra</addr-line>, <country>Ghana</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Epidemiology and Biostatistics, School of Public Health, University of Health and Allied Sciences</institution>, <addr-line>Hohoe</addr-line>, <country>Ghana</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen</institution>, <addr-line>Copenhagen</addr-line>, <country>Denmark</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department for Congenital Disorders, Statens Serum Institute</institution>, <addr-line>Copenhagen</addr-line>, <country>Denmark</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Infectious Diseases</institution>, <addr-line>Rigshospitalet, Copenhagen</addr-line>, <country>Denmark</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Paul Giacomin, James Cook University, Australia</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Rhea Jessica Longley, The University of Melbourne, Australia; Kingsley Badu, Kwame Nkrumah University of Science and Technology, Ghana</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Michael F. Ofori, <email xlink:href="mailto:mofori@noguchi.ug.edu.gh">mofori@noguchi.ug.edu.gh</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Immunity and Immune Evasion, a section of the journal Frontiers in Parasitology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>01</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>2</volume>
<elocation-id>1081083</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>10</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>01</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Kyei-Baafour, Kusi, Oppong, Frempong, Aculley, Ofori, Theisen, Kweku, Adu, Hviid and Ofori</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Kyei-Baafour, Kusi, Oppong, Frempong, Aculley, Ofori, Theisen, Kweku, Adu, Hviid and Ofori</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>With the decline in malaria transmission due to global efforts, a more sensitive tool is needed to monitor transmission intensity and pattern at the micro-level. Though transmission in a broader area may be similar, factors such as sanitation, practices of open water storage, early morning and evening activities, outdoor sleeping and agricultural practices within communities could cause differences in exposure and thus transmission. This study thus probed malaria transmission at a micro-level using serology in the Hohoe Municipality of Ghana.</p>
</sec>
<sec>
<title>Methods</title>
<p>This cross-sectional study involved 327 asymptomatic children aged 1-12 years in both rural (196) and urban (131) communities in the Hohoe municipality. Total IgG responses specific for three P. falciparum antigens (CSP, MSP2-FC27, MSP2-3D7) were determined in plasma eluted from dried blood spots using indirect ELISA.</p>
</sec>
<sec>
<title>Results</title>
<p>A higher proportion of individuals in the rural area had parasites by both microscopy and PCR. Total IgG levels and seroprevalence were higher in rural compared to urban communities (p&lt;0.05). In a multiple regression model, adjusting for confounders, levels of PfMSP2-3D7-specific IgG was associated with the higher transmission which occurs in the rural community.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The results suggest that though the district is categorized as having medium malaria transmission, differences within settlements may influence malaria transmission reflecting in antibody levels and prevalence of malaria antigen-specific IgG.</p>
</sec>
</abstract>
<kwd-group>
<kwd>malaria</kwd>
<kwd>serology</kwd>
<kwd>
<italic>Plasmodium falciparum</italic>
</kwd>
<kwd>micro-differences</kwd>
<kwd>transmission</kwd>
<kwd>immunoglobulin G</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="41"/>
<page-count count="10"/>
<word-count count="3883"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Malaria caused by <italic>Plasmodium falciparum</italic> is a major health care challenge in sub-Saharan Africa (SSA). The burden of malaria is high with an estimated 94% of all malaria deaths occurring in SSA (<xref ref-type="bibr" rid="B39">WHO, 2020</xref>). Over the last two decades, local transmission of malaria in some countries in Africa is declining, and child mortality has also dropped as a result of the control measures adopted by governments (<xref ref-type="bibr" rid="B6">Campbell and Steketee, 2011</xref>).</p>
<p>In Ghana, about 30% of out-patients in health facilities have malaria (<xref ref-type="bibr" rid="B29">NMCP, 2016</xref>). Malaria transmission in Ghana is seasonal, varying from high in the rainy season to low in the dry season. Malaria transmission also differs according to the three ecological zones of Ghana, being low in the coastal scrub, medium in the semi-deciduous and transitional forest, and high in the guinea savanna zone (<xref ref-type="bibr" rid="B1">Afari et&#xa0;al., 1992</xref>).</p>
<p>The conventional tools used in estimating malaria transmission intensity are entomological inoculation rates (EIR) based on human landing catches and parasite prevalence (<xref ref-type="bibr" rid="B12">Hay et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B8">Corran et&#xa0;al., 2007</xref>). Alternative methods such as serology (antibody responses to vector-specific or parasite-specific antigens) have been proposed and tested to be robust and sensitive (<xref ref-type="bibr" rid="B8">Corran et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B5">Badu et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B17">Kusi et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B4">Badu et&#xa0;al., 2015</xref>). Serology can thus reveal micro-differences in a larger transmission zone, especially those with medium to low transmission. Local parasite transmission is dependent on environmental factors, land use, human settlements and behaviour, which may influence vector abundance and thus parasite transmission patterns (<xref ref-type="bibr" rid="B40">Yankson et&#xa0;al., 2019</xref>).</p>
<p>
<italic>Plasmodium falciparum</italic> merozoite surface protein 2 (<italic>Pf</italic>MSP2) is a glycoprotein which is encoded by the MSP2 gene on chromosome 2. It is made up of five blocks with the central block being the most polymorphic. MSP2 is one of the numerous malaria vaccine candidates under consideration for a vaccine (<xref ref-type="bibr" rid="B13">Howard and Pasloske, 1993</xref>). However, it exhibits extensive polymorphism and the genes of MSP2 in the block 3 regions of MSP2 have alleles grouped into two families, the IC3D7 and FC27 (<xref ref-type="bibr" rid="B36">Smythe et&#xa0;al., 1991</xref>). These have been used to determine the multiplicity of <italic>P. falciparum</italic> infection (<xref ref-type="bibr" rid="B10">Felger et&#xa0;al., 1994</xref>) which is an indication of the diversity of the circulation parasites in an area. <italic>Plasmodium falciparum</italic> circumsporozoite protein (CSP) is a protein expressed extensively on sporozoite surfaces (<xref ref-type="bibr" rid="B25">M&#xe9;nard et&#xa0;al., 1997</xref>), and exposed to the immune system for a brief time after an infectious bite. Meaning anti-CSP antibodies may have a relatively shorter half-life (<xref ref-type="bibr" rid="B16">Kerkhof et&#xa0;al., 2016</xref>) than most blood-stage antigens, and thus positive responses may indicate a recent infection. With the recent decline in malaria transmission, it is becoming increasingly difficult to use the conventional entomological inoculation rate (EIR) or parasite prevalence to estimate transmission intensity due to the very low prevalence of infected mosquitoes, thus proposing serology as an alternative (<xref ref-type="bibr" rid="B8">Corran et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B34">Rosas-Aguirre et&#xa0;al., 2013</xref>). For example, anti-CSP antibodies have been found to be ideal for monitoring malaria transmission intensity and pattern (<xref ref-type="bibr" rid="B17">Kusi et&#xa0;al., 2014</xref>). We recently reported on the suitability of multiple malaria antigens to estimate transmission intensity and pattern in three ecological zones in the Volta Region of Ghana (<xref ref-type="bibr" rid="B21">Kyei-Baafour et&#xa0;al., 2021</xref>). However, the local differences in transmission intensity and pattern within each ecological zone were not highlighted. Here, we report on the micro-differences in <italic>P. falciparum</italic> transmission within a medium malaria transmission zone in the Hohoe Municipality.</p>
</sec>
<sec id="s2">
<title>Methods</title>
<sec id="s2_1">
<title>Population and study sites</title>
<p>This study involving a total of 327 children aged 1-12 years, was a cross-sectional community-based survey carried out in the Hohoe Municipality of the Volta region of Ghana. Sampling for the study was carried out in December 2018 which was in the dry season. The Hohoe municipality has two major seasons: a rainy season which spans the months of May and October, and a dry season which starts from November and ends in April. The rainfall pattern in the areas around Hohoe is bimodal which peaks in June. There is also a minor peak in October (<xref ref-type="bibr" rid="B30">Ofori et&#xa0;al., 2018</xref>)</p>
<p>The Research Ethics Committee of the University of Health and Allied Sciences (UHAS-REC A.1 (5) 18&#x2013;19) approved the study. Written informed consent was obtained from parents/guardians of the children before sampling. All children sampled had no clinical symptoms. The population and sites of the larger study have been described in detail elsewhere (<xref ref-type="bibr" rid="B32">Oppong et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B21">Kyei-Baafour et&#xa0;al., 2021</xref>).</p>
<p>Briefly, the Hohoe Municipality has a population of about 114,472 out of which 52.6% are urban settlers. The municipality is in a medium transmission zone with a reported malaria prevalence of 7.7% (<xref ref-type="bibr" rid="B19">Kweku et&#xa0;al., 2017</xref>). More than 57% of the rural settlers engage in agriculture. The study sites included Hohoe, the urban settlement which is a commercial town with the biggest market in the municipality and connected with piped water and also hosts the municipal hospital. Godenu and Gbodome were the rural settlements studied, with Godenu located south of, and Gbodome north of Hohoe. The distance between Hohoe and Godenu is about 7km, and from Hohoe to Gbodome is about 9km (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>A map of the study area showing the sampling sites.The figure shows a map of the sampling sites with Hohoe the capital of the municipality (Urban) and the two rural settlements. The Map was created by Dr Prince Asare of the Noguchi Memorial Institute for Medical Research, University of Ghana, using QGIS version 3.4.7.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpara-02-1081083-g001.tif"/>
</fig>
</sec>
<sec id="s2_2">
<title>Sampling and elution of antibodies from dried blood spots</title>
<p>Blood spots from finger pricks were collected on Whatman No. 5 filter paper (GE Healthcare, England) and air-dried. The dried blood spots (DBS) were stored in desiccated bags at 4&#xb0;C until ready for use. Plasma was eluted from the DBS using a protocol described previously (<xref ref-type="bibr" rid="B9">Corran et&#xa0;al., 2008</xref>). Briefly, individually wrapped filter papers were cut to 2.5&#xa0;mm diameter with a leather punch into 96-well round bottom plates. Serum was eluted with 150 &#x3bc;L PBS with 0.05% Tween 20 and 0.05% sodium azide overnight. Eluted serum was stored at -20&#xb0;C for later use.</p>
</sec>
<sec id="s2_3">
<title>Determination of total IgG levels</title>
<p>Antigens selected for this study were expressed in a <italic>Lactococcus lactis</italic> expression system described previously (<xref ref-type="bibr" rid="B35">Singh et&#xa0;al., 2018</xref>). MSP2-3D7 and CSP were cloned from <italic>P. falciparum</italic> strains of 3D7 while MSP2-FVO, was cloned from <italic>P. falciparum</italic> FVO strain. The MSP2 antigens were selected due on their use as molecular markers for the determination of the multiplicity of <italic>P. falciparum</italic> infection (genetic diversity of parasite population) (<xref ref-type="bibr" rid="B41">Zhong et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B26">Mohammed et&#xa0;al., 2021</xref>) thus, this study was to test their suitability as serological markers of malaria transmission intensity estimation. The CSP was used as a control antigen since studies have found it as a useful marker in determining the heterogeneity of malaria transmission intensity and pattern (<xref ref-type="bibr" rid="B17">Kusi et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B18">Kusi et&#xa0;al., 2016</xref>).</p>
<p>Levels of IgG specific for each of the three <italic>Plasmodium falciparum</italic> antigens (MSP2-3D7, MSP2-FC27, and CSP) were determined using indirect ELISA. Briefly, 96-well microtiter plates (Maxisorp Nunc) were coated with 100 &#xb5;L/well of 1 &#xb5;g/mL of antigen in 1&#xd7; PBS, pH of 7.4. The plates were incubated overnight at 4&#xb0;C. Plates were blocked with 5% skimmed milk/PBS and incubated in a humidified chamber at room temperature for 1&#xa0;h. The plates were incubated with 100 &#xb5;L/well-eluted plasma samples and control samples (plasma from 10 na&#xef;ve individuals who have never been to a malaria endemic area), all diluted 200&#xd7; in 3% milk/PBS, for 1 hr. Plate development was done with 100 &#xb5;L/well horseradish peroxidase (HRP) conjugated goat-anti-human IgG (H+L) (Life Technologies, USA) and incubated for 1&#xa0;h. Antibody quantification was done using TMB substrate for 10&#xa0;min in the dark and colour development stopped by the addition of 100 &#xb5;L/well of 0.2&#xa0;N H<sub>2</sub>SO<sub>4</sub>. Optical density (OD) was read at 450 nm. Optical density was converted to antibody unit (AU).</p>
</sec>
<sec id="s2_4">
<title>Data analysis</title>
<p>Antibody units from the na&#xef;ve volunteers were used to define a cut-off for seropositivity. the cut-off for seropositivity was calculated as the mean na&#xef;ve antibody units plus 2 standard deviations of the mean. For each antigen, median antibody levels and seroprevalence were compared among the settlements using the Mann-Whitney test, and chi-square tests respectively. Six samples positive for both <italic>P. falciparum</italic> and <italic>P. malariae</italic> were excluded from the analysis. Associations between each antibody response and settlements were derived from a multivariate logistic regression model, adjusting for confounders and other antigens. Differences were considered statistically significant when p-values &lt;0.05. Data were analyzed using R statistical software version 4.1.2, and figures made with GraphPad Prism version 9.0.0 (121).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Study population</title>
<p>Children from both communities have similar ages, and the proportion of males to females was not statistically different. Bed net usage was also similar between the communities. They also had similar haemoglobin levels. Parasite density between the communities was not different. However, parasite prevalence by microscopy was 3.8% in the urban settlement compared to 9.7% in the rural community p=0.077. A similar trend was observed when prevalence was compared by PCR was between the two communities (7.6% vs 17.3%, p=0.018) for urban versus rural communities (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>)</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Study participant demographics.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="bottom" align="left">Variable</th>
<th valign="bottom" align="center">Urban (n=131)</th>
<th valign="bottom" align="center">Rural (n=196)</th>
<th valign="bottom" align="center">Total (n=327)</th>
<th valign="bottom" align="center">p-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="bottom" align="left">
<bold>Age [mean years (SD)]</bold>
</td>
<td valign="bottom" align="center">5.4 (3.6)</td>
<td valign="bottom" align="center">5.6 (3.1)</td>
<td valign="bottom" align="center">5.6 (3.3)</td>
<td valign="bottom" align="center">0.618*</td>
</tr>
<tr>
<td valign="bottom" colspan="5" align="left">
<bold>Gender</bold>
</td>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;Female</td>
<td valign="bottom" align="center">75 (57.3)</td>
<td valign="bottom" align="center">106 (54.1)</td>
<td valign="bottom" align="center">181 (55.4)</td>
<td valign="bottom" align="center">0.651<sup>$</sup>
</td>
</tr>
<tr>
<th valign="bottom" colspan="5" align="left">Bed net usage (%)</th>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;Yes</td>
<td valign="bottom" align="center">109 (83.2)</td>
<td valign="bottom" align="center">173 (88.3)</td>
<td valign="bottom" align="center">282 (86.2)</td>
<td valign="bottom" align="center">0.255<sup>$</sup>
</td>
</tr>
<tr>
<td valign="bottom" align="left">
<bold>Parasite density [median (IQR)]</bold>
</td>
<td valign="bottom" align="center">960 (320 to 1224)</td>
<td valign="bottom" align="center">720 (440 to 3340)</td>
<td valign="bottom" align="center">780 (350 to 3190)</td>
<td valign="bottom" align="center">0.696<sup>#</sup>
</td>
</tr>
<tr>
<th valign="bottom" colspan="5" align="left">Microscopy [N (%)]</th>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;Positive</td>
<td valign="bottom" align="center">5 (3.8)</td>
<td valign="bottom" align="center">19 (9.7)</td>
<td valign="bottom" align="center">24 (7.3)</td>
<td valign="bottom" align="center">0.075<sup>$</sup>
</td>
</tr>
<tr>
<td valign="bottom" colspan="5" align="left">
<bold>PCR [N (%)]</bold>
</td>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;Positive</td>
<td valign="bottom" align="center">10 (7.6)</td>
<td valign="bottom" align="center">34 (17.3)</td>
<td valign="bottom" align="center">44 (13.5)</td>
<td valign="bottom" align="center">0.018<sup>$</sup>
</td>
</tr>
<tr>
<td valign="bottom" align="left">
<bold>Hb/g/dl [mean (sd)]</bold>
</td>
<td valign="bottom" align="center">11.1 (1.6)</td>
<td valign="bottom" align="center">11.3 (1.8)</td>
<td valign="bottom" align="center">11.2 (1.7)</td>
<td valign="bottom" align="center">0.328*</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>*P value derived using students t-test, $ p value derived using chi-square test, # p value derived using Mann Whitney test.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_2">
<title>Parasitaemia and total IgG levels</title>
<p>Since the proportion of individuals positive for parasitaemia was higher in the rural community, we compared antibody levels between the three different parasite categories (microscopic, sub-microscopic, and those without detectable parasitaemia) in each community. In the urban community, no differences were observed among the three categories. However, those with sub-microscopic parasitemia had higher IgG levels to <italic>Pf</italic>CSP and <italic>Pf</italic>MSP2-3D7 in the rural community (p&lt;0.05 for the two antigens, Kruskal Wallis test. <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Total IgG response between parasitaemic and aparasitaemic children. The box and whisker plot represent log-transformed median IgG levels of children with uninfected, microscopic, and sub-microscopic parasitaemia for each antigen for both the rural and urban settlements. Central lines: medians, Boxes: central 50%, Whiskers: central 90%. Outliers are shown as dots. Kruskal-Wallis test was used to test for overall intergroup differences followed by Dunn&#x2019;s post-hoc test, when overall intergroup statistical significance (p &lt; 0.05).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpara-02-1081083-g002.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>Seroprevalence of <italic>P. falciparum antigen</italic>-specific antibodies</title>
<p>Antibody seroprevalence according to the study communities was analyzed to explore the effects of the different settlements on antigen recognition. Antibody seroprevalence to <italic>Pf</italic>CSP (X<sup>2 =</sup> 4.91. p = 0.03), and <italic>Pf</italic>MSP2-3D7 (X<sup>2</sup> = 12.11, p=0.0005) but not <italic>Pf</italic>MSP2<italic>-</italic>Fc27 were significantly higher in the rural settlements (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Seroprevalence was compared between the urban (black bars), and rural (grey bars) communities. P-values between communities were determined using the Chi-square test and *p = &lt;0.05, *** p = &lt;0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpara-02-1081083-g003.tif"/>
</fig>
<p>Next, we explored and compared the age-specific seroprevalence between the two settlements. The children were categorized into three different age groups: 0-4 years, 5-8 years, and 9-12 years. In the rural settlements, children above nine (9) years had significantly higher antibody seroprevalence to all the antigens (p= 0.009 for <italic>Pf</italic>CSP; p&lt;0.0001 for <italic>Pf</italic>MSP2-Fc27; and p&lt;0.0001 for <italic>Pf</italic>MSP2-3D7). A similar trend was observed in the urban community for <italic>Pf</italic>CSP (p&lt;0.0001), where children above 9 years had significantly higher seroprevalence. However, seroprevalence to <italic>Pf</italic>MSP2-Fc27 was higher in the 5-8-year group (84.1%, x<sup>2 =</sup> 13.3 p=0.003), and responses to <italic>Pf</italic>MSP2-3D7 showed no difference among the age groups (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>)</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Age-related seroprevalence in rural and urban children.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="bottom" colspan="4" align="center">Urban</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="bottom" align="left"/>
<th valign="bottom" align="center">
<italic>Pf</italic>CSP</th>
<th valign="bottom" align="center">
<italic>Pf</italic>MSP2-Fc27</th>
<th valign="bottom" align="center">
<italic>Pf</italic>MSP2-3D7</th>
</tr>
<tr>
<td valign="bottom" align="center">0-4yrs</td>
<td valign="bottom" align="center">45.6</td>
<td valign="bottom" align="center">72.7</td>
<td valign="bottom" align="center">70</td>
</tr>
<tr>
<td valign="bottom" align="center">5-8yrs</td>
<td valign="bottom" align="center">77.2</td>
<td valign="bottom" align="center">84.1</td>
<td valign="bottom" align="center">76.7</td>
</tr>
<tr>
<td valign="bottom" align="center">9-12yrs</td>
<td valign="bottom" align="center">84.2</td>
<td valign="bottom" align="center">61.4</td>
<td valign="bottom" align="center">63.3</td>
</tr>
<tr>
<td valign="bottom" align="left"/>
<td valign="bottom" align="center">X2 = 38.2 p&lt;0.0001</td>
<td valign="bottom" align="center">x2 = 13.3 p=0.003</td>
<td valign="bottom" align="center">X2 = 4.7<break/>p=0.97</td>
</tr>
<tr>
<th valign="bottom" colspan="4" align="center">Rural</th>
</tr>
<tr>
<td valign="bottom" align="center">0-4yrs</td>
<td valign="bottom" align="center">67.9</td>
<td valign="bottom" align="center">66.7</td>
<td valign="bottom" align="center">56.4</td>
</tr>
<tr>
<td valign="bottom" align="center">5-8yrs</td>
<td valign="bottom" align="center">69.2</td>
<td valign="bottom" align="center">88.5</td>
<td valign="bottom" align="center">83.3</td>
</tr>
<tr>
<td valign="bottom" align="center">9-12yrs</td>
<td valign="bottom" align="center">84.6</td>
<td valign="bottom" align="center">94.9</td>
<td valign="bottom" align="center">84.6</td>
</tr>
<tr>
<td valign="bottom" align="left"/>
<td valign="bottom" align="center">X2 = 9.5 p= 0.009</td>
<td valign="bottom" align="center">X2 = 30.7 p&lt;0.0001</td>
<td valign="bottom" align="center">X2 = 27.7 p&lt;0.0001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>P values were generated using a chi-square test.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_4">
<title>Levels of IgG specific to Antibodies</title>
<p>We analyzed the total IgG levels to the three antigens in the rural and urban communities and found that median levels to all the three antigens were higher in the rural community compared to the urban community (p&lt; 0.05; Mann&#x2013;Whitney test, for all three antigens) (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Median total IgG levels between urban and rural settlements. Log transformed antibody responses were determined using ELISA and are shown as a bar with dot plots. The boxes represent the median with error bars showing the upper and lower values. The dots show the distribution of individual antibody levels. Stars represent significantly higher antigens levels between the communities using the Mann-Whitney test. **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpara-02-1081083-g004.tif"/>
</fig>
<p>Levels of total IgG were compared among the three age groups and found children 9 years and above had significantly higher total IgG levels to all the antigens within each community compared to those under 5 years (p&lt;0.05 for all antigens, <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Association of antibody levels with age. Box plot of antibody units (log-transformed) and categorized ages for urban <bold>(A-C)</bold>, and rural <bold>(D-F)</bold> settlements. The error bars represent the minimum and maximum antibody units with the dots representing individual samples in each category. Stars represent significantly higher antigens levels among the three age categories using the Kruskal-Wallis test. *p = &lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpara-02-1081083-g005.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>Association between higher IgG responses and transmission</title>
<p>To determine whether malaria transmission could be predicted using antibody responses, the responses to each of the three antigens were individually analyzed using a multivariate logistic regression model with community of residence as a binary outcome variable and with antibody responses as the predictor variable. For the responses to each antigen, the models were adjusted for sub-microscopic parasitaemia, bed net usage and responses to other antigens. Our data showed that higher responses to MSP2-3D7 increased the odds of having higher malaria transmission in the rural community (OR= 1.37, 95%CI=1.15-1.64, p=0.0006) (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Association between IgG and Transmission.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="bottom" align="center">Antigen</th>
<th valign="bottom" align="center">OR</th>
<th valign="bottom" align="center">95% CI</th>
<th valign="bottom" align="center">p-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="bottom" align="left">
<italic>Pf</italic>MSP2-3D7</td>
<td valign="bottom" align="center">1.37</td>
<td valign="bottom" align="center">1.15 to 1.64</td>
<td valign="bottom" align="center">0.0006</td>
</tr>
<tr>
<td valign="bottom" align="left">
<italic>Pf</italic>MSP2-Fc27</td>
<td valign="bottom" align="center">1.03</td>
<td valign="bottom" align="center">0.82 to1.29</td>
<td valign="bottom" align="center">0.81</td>
</tr>
<tr>
<td valign="bottom" align="left">
<italic>Pf</italic>CSP</td>
<td valign="bottom" align="center">1.09</td>
<td valign="bottom" align="center">0.87 to 1.36</td>
<td valign="bottom" align="center">0.44</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>With the prevalence and transmission of malaria declining, sensitive tools are needed to effectively monitor transmission intensity and pattern at the micro-level. Serology is one key tool used to estimate transmission intensity and pattern because it can detect heterogeneity in transmission intensity at the micro level using antibody responses to malaria antigens.</p>
<p>We set out to determine the association between parasite prevalence and antibody responses to two <italic>P. falciparum</italic> merozoite antigens (MSP2-3D7, MSP2-FC27) and a sporozoite antigen (CSP) within different settlements of the same transmission zone. Our data indicate that the parasite prevalence was higher in rural settlements compared to urban settlements. Also, antibody responses to all antigens were higher in the rural settlements, and antibody seroprevalence to MSP2-3D7, and CSP were also higher in the rural settlements. In a multivariate analysis, we also found responses to <italic>Pf</italic>MSP2-3D7 were associated with high transmission and thus rural settlement. This is consistent with studies from Gabon (<xref ref-type="bibr" rid="B14">Imboumy-Limoukou et&#xa0;al., 2016</xref>) where higher antibody responses were found in rural children compared to those in the urban areas.</p>
<p>Though the larger area of Hohoe municipality and its environs is designated as having medium but seasonal malaria transmission (<xref ref-type="bibr" rid="B1">Afari et&#xa0;al., 1992</xref>; <xref ref-type="bibr" rid="B20">Kweku et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B21">Kyei-Baafour et&#xa0;al., 2021</xref>), the micro-ecological and transmission differences and practices between the rural and urban settlements in the municipality may result in different vector exposure rates. The overall parasite prevalence was 7.3% by microscopy and 13.5% by PCR. Our data indicate that <italic>P. falciparum</italic> was more prevalent in the rural settlements compared to the urban settlement confirming previous reports (<xref ref-type="bibr" rid="B33">Robert et&#xa0;al., 2003</xref>; <xref ref-type="bibr" rid="B24">Louren&#xe7;o, 2012</xref>). The high parasite prevalence in the rural settlements is indicative of higher transmission at those sites compared to the urban centre. The population in the rural communities mostly engage in agrarian activities with rice and vegetables being the main crops farmed. The water used in the rice farms could potentially serve as breeding sites for malaria vectors, thereby increasing the parasite exposure of people living in rural areas. Also, practices in rural settlements such as storing water in open receptacles, coupled with the bushes around could be good breeding grounds for the vectors (<xref ref-type="bibr" rid="B3">Azabre et&#xa0;al., 2013</xref>). Other practices in many rural settlements in Ghana likely to increase the risk of malaria are the habit of sleeping outside, especially in the dry season, and early evening and morning activities (<xref ref-type="bibr" rid="B27">Monroe et&#xa0;al., 2015</xref>). On the other hand, the urban centres have less favourable breeding grounds for vectors due to improved infrastructure and easy access to health care (<xref ref-type="bibr" rid="B23">Lindsay et&#xa0;al., 1990</xref>; <xref ref-type="bibr" rid="B2">Alirol et&#xa0;al., 2011</xref>). That notwithstanding, urbanization without the proper infrastructure may increase vector breeding sites and increase transmission as is recently reported (<xref ref-type="bibr" rid="B28">Mzilahowa et&#xa0;al., 2016</xref>).</p>
<p>We found higher total IgG responses to all the three antigens in the rural settlements compared to the urban settlements. This was confirmed by the higher seroprevalence (the proportion of children&#xa0;that responded to each antigen) in the rural settlements. This higher response may be due to the high parasite prevalence in rural communities. Also, parasitaemic children in the rural communities had higher total IgG responses to MSP2-3D7 and CSP, while no differences were observed in the urban settlements between parasitaemic and non-parasitaemic children. Parasite specific antibody responses can be boosted by <italic>Plasmodium</italic> infection by an estimated 20% increase in level (<xref ref-type="bibr" rid="B15">Kaddumukasa et&#xa0;al., 2015</xref>) and thus the high responses observed in the rural settlements are likely to reflect the higher parasite prevalence there. The low responses and low seroprevalence in the urban settlement may be due to the awareness of the population about malaria-related illness and protecting children from infection risk. Also, some of the practices in the villages, such as storing water in open receptacles, are hardly observed in the urban communities, which are served by piped water. A study comparing antibody responses between older Gambians and younger Ghanaians suggest that the younger children are unable to produce long-lived IgG antibody secreting cells compared to their older counterparts (<xref ref-type="bibr" rid="B38">White et&#xa0;al., 2014</xref>). Thus, children with intermitnent infection such as those in the rural community, are more likely to bost and sustain antibody production comapared to those less exposed (<xref ref-type="bibr" rid="B11">Fowkes et&#xa0;al., 2012</xref>). This may explain the higher responses in the rural children compared to those in the urban area. There are reports of antibody half-lives to different antigens (<xref ref-type="bibr" rid="B31">Ondigo et&#xa0;al., 2014</xref>) where some responses were found to long-lived. This long-lived responses may be a limitation to the use of such antigens to monitor malaria transmission intensity.</p>
<p>In an age-related analysis, high antibody responses, and seroprevalence in rural area in older children supports previous report of age-related antibody acquisition (<xref ref-type="bibr" rid="B37">Stanisic et&#xa0;al., 2015</xref>). Though there was no difference in the ages of the children from both settlements, higher seroprevalence associated with age in the rural settlement may be an indication of higher vector exposure. Interestingly, seroprevalence to MSP2-FC27 in the younger children was high in the urban area and the reason for this is not readily understood. Although Hohoe is an urban settlement, it is also a commercial town, and women are mostly involved in trading. This exposes the younger children who are carried at the back by their mothers to early morning bites when the mothers go out to the market at dawn. Though we do not have data on the specific strains of circulating parasites in our study area, which is a limitation, the specificity of the seroprevalence to MSP2-FC27 in the younger children may be an indication this parasite clone may be the predominant clone in the urban settlement.</p>
<p>In a logistic regression model adjusting for confounders, we found higher odds of responses to MSP2-3D7 to be associated with parasite carriage and thus higher transmission in the rural settlement which may indicate its circulation in the rural settlement. Serology, which was the tool employed in this study has confirmed that in an area of low to medium malaria transmission, micro-differences in transmission can be detected using anti-malaria antibody responses (<xref ref-type="bibr" rid="B17">Kusi et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B18">Kusi et&#xa0;al., 2016</xref>). However, the use of some of these anti-malaria antibody responses such as CSP to monitor transmission intensity and pattern in the future may be challenging with the introduction of RTS,S vaccine. This is because the RTS,S vaccine has CSP as the main component (<xref ref-type="bibr" rid="B7">Cohen et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B22">Laurens, 2020</xref>), and responses to the vaccine induced CSP may dilute naturally acquired responses. Thus, the need to increase the repertoire of antigens.</p>
<p>In summary, the study highlights heterogeneity in malaria transmission at the micro level and also confirms serology as a robust tool for transmission monitoring, especially in low to medium transmission settings. This has implications for malaria control and the administration of vaccines in such communities.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by The Research Ethics Committee of the University of Health and Allied Sciences (UHAS-REC A.1 (5) 18&#x2013;19). Written informed consent to participate in this study was provided by the parent/legal guardian.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>Conceived and designed the experiments: EK-B, LH, MK and MFO. Performed the experiments: EK-B, MO, AF, BAc, EAO. Analyzed the data: EK-B, KK, and MFO. Contributed reagents/materials/analysis tools: KK, BA, and MT. Wrote the manuscript: EK-B, KK, BA, LH and MFO. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The study was supported by the Danish Research Council for Development Research (FFU) led by LH and MFO (Grant No. 17&#x2013;02-KU).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We would like to thank the participants, and parents/guardians for participating in the study. The technical assistance of Mr. Jovis Williams and Miss Sophia Eyia-Ampah both of the Immunology Department, NMIMR. We also thank all the Field staff, for their enormous support during the sample collection.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors&#xa0;and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Afari</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Akanmori</surname> <given-names>B. D.</given-names>
</name>
<name>
<surname>Nakano</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ofori-Adjei</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Plasmodium falciparum: sensitivity to chloroquine <italic>in vivo</italic> in three ecological zones in Ghana</article-title>. <source>Trans. R Soc. Trop. Med. Hyg.</source> <volume>86</volume> (<issue>3</issue>), <fpage>231</fpage>&#x2013;<lpage>232</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0035-9203(92)90285-K</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alirol</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Getaz</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Stoll</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Chappuis</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Loutan</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Urbanisation and infectious diseases in a globalised world</article-title>. <source>Lancet Infect. Dis.</source> <volume>11</volume> (<issue>2</issue>), <fpage>131</fpage>&#x2013;<lpage>141</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1473-3099(10)70223-1</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azabre</surname> <given-names>B. A.</given-names>
</name>
<name>
<surname>Teye</surname> <given-names>J. K.</given-names>
</name>
<name>
<surname>Yaro</surname> <given-names>J. A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Malaria control strategies in the kassena-nankana east and west districts of Ghana</article-title>. <source>Ghana J. Geogr.</source> <volume>5</volume>, <fpage>102</fpage>&#x2013;<lpage>120</lpage>.</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Badu</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Gyan</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Appawu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Mensah</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Dodoo</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Serological evidence of vector and parasite exposure in southern Ghana: the dynamics of malaria transmission intensity</article-title>. <source>Parasit Vectors</source> <volume>8</volume>, <fpage>251</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13071-015-0861-y</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Badu</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Siangla</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Larbi</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lawson</surname> <given-names>B. W.</given-names>
</name>
<name>
<surname>Afrane</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Ong&#x2019;echa</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Variation in exposure to anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands</article-title>. <source>Malaria J.</source> <volume>11</volume> (<issue>1</issue>), <fpage>318</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1475-2875-11-318</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campbell</surname> <given-names>C. C.</given-names>
</name>
<name>
<surname>Steketee</surname> <given-names>R. W.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Malaria in Africa can be eliminated</article-title>. <source>Am. J. Trop. Med. Hygiene</source> <volume>85</volume> (<issue>4</issue>), <fpage>584</fpage>&#x2013;<lpage>585</lpage>. doi: <pub-id pub-id-type="doi">10.4269/ajtmh.2011.11-0529</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Nussenzweig</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Vekemans</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Leach</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>From the circumsporozoite protein to the RTS,S/AS candidate vaccine</article-title>. <source>Hum. Vaccines</source> <volume>6</volume> (<issue>1</issue>), <fpage>90</fpage>&#x2013;<lpage>96</lpage>. doi: <pub-id pub-id-type="doi">10.4161/hv.6.1.9677</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corran</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Coleman</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Riley</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Drakeley</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Serology: A robust indicator of malaria transmission intensity</article-title>? <source>Trends Parasitol.</source> <volume>23</volume> (<issue>12</issue>), <page-range>575&#x2013;582</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pt.2007.08.023</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corran</surname> <given-names>P. H.</given-names>
</name>
<name>
<surname>Cook</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lynch</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Leendertse</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Manjurano</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Griffin</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Dried blood spots as a source of anti-malarial antibodies for epidemiological studies</article-title>. <source>Malar J.</source> <volume>7</volume>, <page-range>195</page-range>. doi: <pub-id pub-id-type="doi">10.1186/1475-2875-7-195</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Felger</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Tavul</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Kabintik</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Marshall</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Genton</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Alpers</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>1994</year>). <article-title>Plasmodium falciparum: extensive polymorphism in merozoite surface antigen 2 alleles in an area with endemic malaria in Papua new Guinea</article-title>. <source>Exp. Parasitol.</source> <volume>79</volume> (<issue>2</issue>), <fpage>106</fpage>&#x2013;<lpage>116</lpage>. doi: <pub-id pub-id-type="doi">10.1006/expr.1994.1070</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fowkes</surname> <given-names>F. J.</given-names>
</name>
<name>
<surname>McGready</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Cross</surname> <given-names>N. J.</given-names>
</name>
<name>
<surname>Hommel</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Simpson</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Elliott</surname> <given-names>S. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women</article-title>. <source>J. Infect. Dis.</source> <volume>206</volume> (<issue>10</issue>), <fpage>1612</fpage>&#x2013;<lpage>1621</lpage>. doi: <pub-id pub-id-type="doi">10.1093/infdis/jis566</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hay</surname> <given-names>S. I.</given-names>
</name>
<name>
<surname>Rogers</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Toomer</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>Snow</surname> <given-names>R. W.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Annual plasmodium falciparum entomological inoculation rates (EIR) across Africa: literature survey, Internet access and review</article-title>. <source>Trans. R. Soc. Trop. Med. Hygiene</source> <volume>94</volume> (<issue>2</issue>), <fpage>113</fpage>&#x2013;<lpage>127</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0035-9203(00)90246-3</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howard</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Pasloske</surname> <given-names>B. L.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Target antigens for asexual malaria vaccine development</article-title>. <source>Parasitol. Today</source> <volume>9</volume> (<issue>10</issue>), <fpage>369</fpage>&#x2013;<lpage>372</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0169-4758(93)90085-T</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imboumy-Limoukou</surname> <given-names>R.-K.</given-names>
</name>
<name>
<surname>Oyegue-Liabagui</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Ndidi</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Pegha-Moukandja</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Kouna</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Galaway</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Comparative antibody responses against three antimalarial vaccine candidate antigens from urban and rural exposed individuals in Gabon</article-title>. <source>Eur. J. Microbiol. Immunol.</source> <volume>6</volume> (<issue>4</issue>), <fpage>287</fpage>&#x2013;<lpage>297</lpage>. doi: <pub-id pub-id-type="doi">10.1556/1886.2016.00027</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaddumukasa</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lwanira</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Lugaajju</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Katabira</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Persson</surname> <given-names>K. E. M.</given-names>
</name>
<name>
<surname>Wahlgren</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Parasite specific antibody increase induced by an episode of acute p. falciparum uncomplicated malaria</article-title>. <source>PLoS One</source> <volume>10</volume> (<issue>4</issue>), <elocation-id>e0124297</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0124297</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kerkhof</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Sluydts</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Willen</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Canier</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Heng</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Serological markers to measure recent changes in malaria at population level in Cambodia</article-title>. <source>Malaria J.</source> <volume>15</volume> (<issue>1</issue>), <fpage>529</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12936-016-1576-z</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kusi</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Bosomprah</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Dodoo</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Kyei-Baafour</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Dickson</surname> <given-names>E. K.</given-names>
</name>
<name>
<surname>Mensah</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation</article-title>. <source>Malar J.</source> <volume>13</volume>, <fpage>103</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1475-2875-13-103</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kusi</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Bosomprah</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kyei-Baafour</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Dickson</surname> <given-names>E. K.</given-names>
</name>
<name>
<surname>Tornyigah</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Angov</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Seroprevalence of antibodies against plasmodium falciparum sporozoite antigens as predictive disease transmission markers in an area of Ghana with seasonal malaria transmission</article-title>. <source>PLoS One</source> <volume>11</volume> (<issue>11</issue>), <elocation-id>e0167175</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0167175</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kweku</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Appiah</surname> <given-names>E. K.</given-names>
</name>
<name>
<surname>Enuameh</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Adjuik</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Takramah</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Tarkang</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>The impact of malaria control interventions on malaria and anaemia in children under five after ten years of implementation in the hohoe municipality of Ghana</article-title>. <source>Adv. Infect. Dis.</source> <volume>7</volume> (<issue>03</issue>), <fpage>93</fpage>. doi: <pub-id pub-id-type="doi">10.4236/aid.2017.73010</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kweku</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Appiah</surname> <given-names>E. K.</given-names>
</name>
<name>
<surname>Takramah</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Enuameh</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Norman</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Binka</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Effect of a malaria control program on the prevalence of malaria, fever and anaemia in children under five years in the hohoe municipality of Ghana: a comparative analysis of cross-sectional surveys</article-title>. <source>Adv. Infect. Dis.</source> <volume>5</volume> (<issue>04</issue>), <fpage>180</fpage>. doi: <pub-id pub-id-type="doi">10.4236/aid.2015.54023</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kyei-Baafour</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Oppong</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kusi</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Frempong</surname> <given-names>A. F.</given-names>
</name>
<name>
<surname>Aculley</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Arthur</surname> <given-names>F. K.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Suitability of IgG responses to multiple plasmodium falciparum antigens as markers of transmission intensity and pattern</article-title>. <source>PLoS One</source> <volume>16</volume> (<issue>4</issue>), <elocation-id>e0249936</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0249936</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laurens</surname> <given-names>M. B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>RTS,S/AS01 vaccine (Mosquirix&#x2122;): an overview</article-title>. <source>Hum. Vaccin Immunother.</source> <volume>16</volume> (<issue>3</issue>), <fpage>480</fpage>&#x2013;<lpage>489</lpage>. doi: <pub-id pub-id-type="doi">10.1080/21645515.2019.1669415</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindsay</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Campbell</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Adiamah</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Greenwood</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Bangali</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Greenwood</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Malaria in a peri-urban area of the Gambia</article-title>. <source>Ann. Trop. Med. Parasitol.</source> <volume>84</volume> (<issue>6</issue>), <fpage>553</fpage>&#x2013;<lpage>562</lpage>. doi: <pub-id pub-id-type="doi">10.1080/00034983.1990.11812510</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Louren&#xe7;o</surname> <given-names>A. E. P.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The meaning of &#x2018;rural&#x2019;in rural health: a review and case study from Brazil</article-title>. <source>Global Public Health</source> <volume>7</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/17441692.2011.552513</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>M&#xe9;nard</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Sultan</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Cortes</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Altszuler</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Van Dijk</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Janse</surname> <given-names>C. J.</given-names>
</name>
<etal/>
</person-group>. (<year>1997</year>). <article-title>Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes</article-title>. <source>Nature</source> <volume>385</volume> (<issue>6614</issue>), <fpage>336</fpage>&#x2013;<lpage>340</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/385336a0</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohammed</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Assefa</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Chernet</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Wuletaw</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Commons</surname> <given-names>R. J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Genetic polymorphisms of plasmodium falciparum isolates from melka-werer, north East Ethiopia based on the merozoite surface protein-2 (msp-2) gene as a molecular marker</article-title>. <source>Malaria J.</source> <volume>20</volume> (<issue>1</issue>), <fpage>85</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12936-021-03625-1</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monroe</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Asamoah</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Lam</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Koenker</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Psychas</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Lynch</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Outdoor-sleeping and other night-time activities in northern Ghana: implications for residual transmission and malaria prevention</article-title>. <source>Malaria J.</source> <volume>14</volume> (<issue>1</issue>), <fpage>35</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12936-015-0543-4</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mzilahowa</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Luka-Banda</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Uzalili</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Mathanga</surname> <given-names>D. P.</given-names>
</name>
<name>
<surname>Campbell</surname> <given-names>C. H.</given-names> <suffix>Jr.</suffix>
</name>
<name>
<surname>Mukaka</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Risk factors for anopheles mosquitoes in rural and urban areas of Blantyre district, southern Malawi</article-title>. <source>Malawi Med. J.</source> <volume>28</volume> (<issue>4</issue>), <fpage>154</fpage>&#x2013;<lpage>158</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4314/mmj.v28i4.2</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="book">
<person-group person-group-type="author">
<collab>NMCP</collab>
</person-group> (<year>2016</year>). <source>2015 ANNUAL REPORT</source> (<publisher-loc>Accra</publisher-loc>: <publisher-name>Ghana Health Service</publisher-name>).</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ofori</surname> <given-names>M. F.</given-names>
</name>
<name>
<surname>Lamptey</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Dickson</surname> <given-names>E. K.</given-names>
</name>
<name>
<surname>Kyei-Baafour</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Hviid</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Etiology of placental plasmodium falciparum malaria in African women</article-title>. <source>J. Infect. Dis.</source> <volume>218</volume> (<issue>2</issue>), <fpage>277</fpage>&#x2013;<lpage>281</lpage>. doi: <pub-id pub-id-type="doi">10.1093/infdis/jiy168</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ondigo</surname> <given-names>B. N.</given-names>
</name>
<name>
<surname>Hodges</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Ireland</surname> <given-names>K. F.</given-names>
</name>
<name>
<surname>Magak</surname> <given-names>N. W. G.</given-names>
</name>
<name>
<surname>Lanar</surname> <given-names>D. E.</given-names>
</name>
<name>
<surname>Dutta</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple plasmodium falciparum antigens</article-title>. <source>J. Infect. Dis.</source> <volume>210</volume> (<issue>7</issue>), <fpage>1123</fpage>&#x2013;<lpage>1132</lpage>. doi: <pub-id pub-id-type="doi">10.1093/infdis/jiu225</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oppong</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lamptey</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Kyei-Baafour</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Aculley</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Ofori</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Tornyigah</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Prevalence of sickle cell disorders and malaria infection in children aged 1&#x2013;12 years in the Volta region, Ghana: A community-based study</article-title>. <source>Malaria J.</source> <volume>19</volume> (<issue>1</issue>), <fpage>426</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12936-020-03500-5</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robert</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Macintyre</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Keating</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Trape</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>Duchemin</surname> <given-names>J. B.</given-names>
</name>
<name>
<surname>Warren</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2003</year>). <article-title>Malaria transmission in urban sub-Saharan Africa</article-title>. <source>Am. J. Trop. Med. Hyg.</source> <volume>68</volume> (<issue>2</issue>), <fpage>169</fpage>&#x2013;<lpage>176</lpage>. doi: <pub-id pub-id-type="doi">10.4269/ajtmh.2003.68.169</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosas-Aguirre</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Llanos-Cuentas</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Speybroeck</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Cook</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Contreras-Mancilla</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Soto</surname> <given-names>V.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Assessing malaria transmission in a low endemicity area of north-western Peru</article-title>. <source>Malaria J.</source> <volume>12</volume> (<issue>1</issue>), <fpage>339</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1475-2875-12-339</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Tiendrebeogo</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Chourasia</surname> <given-names>B. K.</given-names>
</name>
<name>
<surname>Kana</surname> <given-names>I. H.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Theisen</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Lactococcus lactis provides an efficient platform for production of disulfide-rich recombinant proteins from plasmodium falciparum</article-title>. <source>Microb. Cell Fact.</source> <volume>17</volume> (<issue>1</issue>), <fpage>55</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12934-018-0902-2</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smythe</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Coppel</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Day</surname> <given-names>K. P.</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>R. K.</given-names>
</name>
<name>
<surname>Oduola</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Kemp</surname> <given-names>D. J.</given-names>
</name>
<etal/>
</person-group>. (<year>1991</year>). <article-title>Structural diversity in the plasmodium falciparum merozoite surface antigen 2</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>88</volume> (<issue>5</issue>), <fpage>1751</fpage>&#x2013;<lpage>1755</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.88.5.1751</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanisic</surname> <given-names>D. I.</given-names>
</name>
<name>
<surname>Fowkes</surname> <given-names>F. J.</given-names>
</name>
<name>
<surname>Koinari</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Javati</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Kiniboro</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Acquisition of antibodies against plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response</article-title>. <source>Infect. Immun.</source> <volume>83</volume> (<issue>2</issue>), <fpage>646</fpage>&#x2013;<lpage>660</lpage>. doi: <pub-id pub-id-type="doi">10.1128/IAI.02398-14</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname> <given-names>M. T.</given-names>
</name>
<name>
<surname>Griffin</surname> <given-names>J. T.</given-names>
</name>
<name>
<surname>Akpogheneta</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Conway</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Koram</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Riley</surname> <given-names>E. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Dynamics of the antibody response to plasmodium falciparum infection in African children</article-title>. <source>J. Infect. Dis.</source> <volume>210</volume> (<issue>7</issue>), <fpage>1115</fpage>&#x2013;<lpage>1122</lpage>. doi: <pub-id pub-id-type="doi">10.1093/infdis/jiu219</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="book">
<person-group person-group-type="author">
<collab>WHO</collab>
</person-group> (<year>2020</year>). <source>World malaria report 2020: 20 years of global progress and challenges</source> <volume>2020</volume> (<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>). Available at: <uri xlink:href="https://apps.who.int/iris/handle/10665/337660">https://apps.who.int/iris/handle/10665/337660</uri>.</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yankson</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Anto</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Chipeta</surname> <given-names>M. G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Geostatistical analysis and mapping of malaria risk in children under 5 using point-referenced prevalence data in Ghana</article-title>. <source>Malaria J.</source> <volume>18</volume> (<issue>1</issue>), <fpage>67</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12936-019-2709-y</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Koepfli</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Molecular approaches to determine the multiplicity of plasmodium infections</article-title>. <source>Malar J.</source> <volume>17</volume> (<issue>1</issue>), <fpage>172</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12936-018-2322-5</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>